BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Elder Pharmaceutical Ltd. Posts Good Results For Q1 Ended Jun'10 - Net Profit Up By 64%


7/27/2010 11:39:10 AM

Elder Pharmaceuticals Ltd, (NSE SYMBOL – ELDERPHARM) an integrated pharmaceuticals company headquartered in Mumbai, has posted excellent standalone results for the first quarter ended June 2010 (Q1 FY2011). As per the unaudited provisional standalone results taken on record on 27th July 2010, the income from operations has gone up to Rs 191.09 India -- Crore for Q1 FY2011 as compared to Rs. 162.90 Crore during the corresponding quarter in the previous year. The operating profit (PBIDT) too has gone up to Rs 39.50 Crore for Q1 FY2011 reflecting a growth of 46% over the previous corresponding quarter’s figure of Rs 26.97 Crore. The Net Profit too has gone up to Rs 18.87 Crore (previous year’s quarter - Rs 11.48 Crore) – a jump of 64%. The EPS on a non – annualized basis comes to Rs 10.01.

The various international alliances of the company, new manufacturing facilities, launch of newer products, penetration into Rural & Semi-Urban markets and strong growth in the traditional products have contributed to the company’s better working.

During the quarter ended June 2010, Elder commenced commercial operations at its new state-of-the-art, US FDA compliant manufacturing facility located in the excise free zone at Langa Road, Dehradun (Uttarakhand), added marketing personnel to strengthen its existing field force, hiked stake in its Bulgarian subsidiary to 61% and launched Ecozyme, a nutraceutical and Elder NRT, a smoking cessation product.

Elder Pharmaceuticals has presence in niche therapeutic segments like Women’s healthcare, Wound care, Nutraceuticals /vitamin Supplements, Cardiology, Diabetes, Dermatology, Antibiotics and neurology. It is the market leader in calcium supplements (Shelcal), wound healing and injectable B12 vitamin. The company has a judicious mix of drug formulations, and active pharma ingredients (APIs). It has 6 manufacturing plants in India located in Maharashtra, Uttarakhand & Himachal Pradesh. The company has a state-of-the-art Research & Development Centre at Navi Mumbai which is recognized by the Department of Scientific & Industrial Research, Ministry of Science & Technology. (www.elderindia.com).



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES